MIT engineers have found a way to boost the effectiveness of cancer immunotherapy drugs called checkpoint inhibitors. They showed that if they treated mice with these drugs along with new nanoparticles that stimulate the immune system, the therapy became more powerful than checkpoint inhibitors given alone.
